Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
7m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
34m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Werewolf Therapeutics Inc logo

Werewolf Therapeutics Inc

About

Werewolf Therapeutics Inc (NASDAQ:HOWL) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 27 2026
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Feb 24 2026
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives
Dec 18 2025
Werewolf Therapeutics Announces Pipeline and Business Updates
Nov 7 2025
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Nov 4 2025
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Financials

Revenue
$0
Market Cap
$49.08 M
EPS
-1.33

Community Chat

Ask AI

6ix6ixAIEvents